Xr Securities LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Xr Securities LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 05, 2024	SELL	$883.2 - $1071.19 $3.44 Million - $4.18 Million	-3,900 Reduced 70.91%	1,600 $1.68 Million
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $3.25 Million - $3.58 Million	-3,600 Reduced 39.56%	5,500 $5.29 Million
Q4 2023 Feb 02, 2024	BUY	$775.18 - $881.7 $3.88 Million - $4.41 Million	5,000 Added 121.95%	9,100 $7.99 Million
Q3 2023 Oct 26, 2023	BUY	$692.45 - $844.37 $830,940 - $1.01 Million	1,200 Added 41.38%	4,100 $3.37 Million
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $70,003 - $83,035	100 Added 3.57%	2,900 $2.08 Million
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $476,343 - $578,879	700 Added 33.33%	2,800 $2.3 Million
Q4 2022 Jan 23, 2023	BUY	$705.89 - $766.39 $1.48 Million - $1.61 Million	2,100 New	2,100 $0
Q3 2019 Oct 03, 2019	SELL	$273.46 - $318.39 $1.12 Million - $1.31 Million	-4,100 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$299.6 - $414.82 $1.23 Million - $1.7 Million	4,100 New	4,100 $255,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.